CureSureMedico
|
HA

Multiple Sclerosis & Movement Disorder Treatment

Neurology

payments

Daga

$5,000

Har zuwa $30,000 ya danganta da cibiya

schedule

Tsawon lokaci na yau da kullum

10–30 days

Hada da gwaje-gwajen kafin tiyata

arrow_downwardlocal_hospital

Asibitocin hadin gwiwa

0

An duba su don bayanan sakamako da takardar shaida

Bayyani

Karɓar kimantawa ta neurological ƙwararru da samun damar mafi sabon jiyya ta canza cuta (DMTs), jiyya ta infusion, da kulawa ƙwararru don multiple sclerosis, cutar Parkinson, da sauran matsalolin motsi. Manyan cibiyoyin neurology a Indiya da Isra'ila suna ba da asibiti na MS da aka amince da su ta kasa da kasa da shirye-shiryen matsalolin motsi da farashi mai raguwa sosai.

Ana daidaita al'amarinku da cibiya bisa bayanan sakamako na likitanci, ba talla ba. Muna tsara kowane mataki — daga gwaje-gwajen kafin tiyata zuwa biye-biye bayan jiyya — tare da mai tsara kulawa na musamman.

Abinda ya hada

Cikakken kimanta jijiyoyi & bitar gano cuta
Daukar hoton MRI na kwakwalwa & kashin baya tare da rahoton ƙwararre
Ba da magani ta DMT ko aikin HSCT kamar yadda aka nuna
Sa ido a asibiti & kulawar jinya a lokacin magani
Mai daidaita kula, mai fassara, & jagorar kulawa
Cikakken tsarin fita tare da hulɗa da likitan jijiyoyi na ƙasar gida

Multiple Sclerosis & Movement Disorder Treatment

An tsara daga

$5,000

ko aiko mana sako a kan WhatsApp

Ba a bukatar alkawari. Ba a taba raba bayananku da wasu jam'iyyu ba.

Kwatancen farashi na duniya — Multiple Sclerosis & Movement Disorder Treatment

Matsakaicin farashi da aka tsara a fadin cibiyoyinmu na hadin gwiwa. Farashin karshe ya danganta da tsananin yanayi da asibitin da aka zaba.

KasaMatsakaicin farashiidan aka kwatanta da mafi araha
🇮🇳

India

New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi

Mafi Kima
$6,000
chevron_right
🇹🇷

Turkey

Istanbul

$18,750
chevron_right

Farashi alama ce kuma ana bita su kowane kwata. Nemi kimar musamman don al'amarinku.

Tambayoyin da ake yawan yi

Yes — this is one of the most common reasons MS patients seek care internationally. Countries like India and Turkey have access to approved DMTs (including natalizumab, ocrelizumab, and alemtuzumab) at 40–70% lower cost than in the US, UK, or Africa. Some treatments like HSCT for MS are also available in accredited centers in India and Turkey but remain experimental or inaccessible in many countries. Our coordinators will review your current diagnosis, MRI reports, and treatment history to match you with the most appropriate center and treatment protocol.

Babu kudi. Babu alkawari.

Jagoranmu kyauta ne gaba daya

Asibitocinmu na hadin gwiwa ne suke biyanmu — ba majinyata ba. Kuna samun daidaita likitanci mai zaman kansa, bayyana farashi, da cikakken tsari ba tare da kudi a kanku ba.

Aiko mana sako a kan WhatsApp